Skip to content

Clinical trial to evaluate the efficacy and safety of Gold Mae-sun therapy on degenerative knee osteoarthritis

A 8-week, investigator-initiated clinical trial to evaluate the efficacy and safety of gold Mae-sun therapy on patients with degenerative knee osteoarthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0003968
Enrollment
30
Registered
2019-05-22
Start date
2019-11-01
Completion date
Unknown
Last updated
2019-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Participants who met the inclusion criteria are randomised to experimental group(gold mae-sun therapy group) or control group(sham group). - Experimental group 1) Treatment method:

Sponsors

Wonkwang University, Gwangju Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. 50 to 80 years old 2. A person who diagnosed primary osteoarthritis on American college of rheumatology criteria a. A person who currently has pain in on or both knees b. Person who over at least three of the following sis criteria 1) Age: 50 to 80 years old 2) A person who knee joints are not more than 30 minutes stiffness in the morning 3) Crepitus of knee joint 4) Bony tenderness 5) Bony enlargement 6) No palpable warmth 3. A person who 100mm VAS(visual analogue scale) pain is more than average 40 points per day (for a week) 4. Those who have heard the full explanation of this human application test, fully understand it, and have voluntarily decided to participate and have agreed in writing to comply with the precautions.

Exclusion criteria

Exclusion criteria: 1. A person who had a steriod injecionin the joint cavity(within the last 3 months). 2. A person who received an viscosupplement(hylan, sodium hyaluronate, hyalulonan etc.) injection in the joint cavity(within the last 6 months). 3. A person who eliminated to expel joint fluid from joint cavity(within the last 6 months). 4. Those with past history or current history such as inflammoatory disease, tumor, rheumarthritis, autoimmune dieases and degeneratio of knee(serious valgus, varus ets.) 5. those who particiapate in other osteoarthritis clinical studies(3 months before screening) 6. Subjects with connective tissue(collagen) disease 7. Subjects with multiple sclerosis disease 8. A person taking immunosuppressant, corticosteroid, cyclosporin 9. A person who experienced to antisychotics treatment(within 3 months before screening test) 10. those who have a history of drug or alcohol abuse 11. Female patients who are pregnant or breastfeeding 12. Diagnostic test A person who is determined by the Principal inspector to be ineligible for research due to medical examination results or other reasons

Design outcomes

Primary

MeasureTime frame
Change of 100mm VAS(visual analog scale)

Secondary

MeasureTime frame
Change of 100mm VAS(visual analog scale);Changes of K-WOMAC(Korean version-Western Ontario and McMaster Universities Questionnaire) total score and subscores;Changes of SF-36(Short-Foam 36 health survey) subscores;Change of physical function test;Adverse events;laboratory test vlaue;Vital sign

Countries

Korea, Republic of

Contacts

Public ContactYoung Kwon

Wonkwang University, Gwangju Medical Center

exeterin@naver.com+82-62-670-6452

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026